Showing results (21-30 of 168) with videos related to
Sort By:
Pageof 17
Archivum Immunologiae Et Therapiae Experimentalis|August 15, 1998
Immunoregulatory role of soluble HLA molecules: a new skin for an old subject?F Puppo, M Ghio, P Contini, et al.Blood|February 25, 1999
Soluble HLA class I, HLA class II, and Fas ligand in blood components: a possible key to explain the immunomodulatory effects of allogeneic blood transfusionsM Ghio, P Contini, C Mazzei, et al.International Immunology|February 2, 2000
Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8(+) Fas (CD95)(+) T lymphocytesF Puppo, P Contini, M Ghio, et al.Human Immunology|August 1, 1994
Increased level of serum HLA class I antigens in HIV infection. Correlation with disease progressionF Puppo, S Brenci, L Lanza, et al.Journal of Hypertension|September 1, 1992
Norepinephrine-induced plasma dopamine decrease in man: pharmacological evidence of the involvement of alpha 2-adrenoceptorsN R Musso, R Gianrossi, C Vergassola, et al.Nephron|January 1, 1989
Free and sulfoconjugated catecholamines in normotensive uremic patients: effects of hemodialysisN R Musso, G Deferrari, A Pende, et al.Journal of Clinical Immunology|July 1, 1995
Behavior of soluble HLA class I antigens in patients with chronic hepatitis C during interferon therapy: an early predictor marker of response?F Puppo, A Picciotto, S Brenci, et al.Journal of Clinical Laboratory Analysis|January 1, 1991
Simple ELISA method for the evaluation of soluble HLA class I antigens in human serumS Comuzio, F Puppo, R Ruzzenenti, et al.Human Immunology|April 15, 1997
Soluble HLA class I and class II molecule levels in serum and cerebrospinal fluid of multiple sclerosis patientsG Filaci, P Contini, S Brenci, et al.Journal of Clinical Immunology|February 24, 2001
Soluble beta2-mu-associated and beta2-mu-free HLA class I heavy chain serum levels in interferon-alpha nonresponder chronic hepatitis C patients. Markers of immune activation, and response to antiviral retreatmentF Puppo, F Torre, P Contini, et al.Pageof 17